CN102232073A - 新化合物i - Google Patents
新化合物i Download PDFInfo
- Publication number
- CN102232073A CN102232073A CN2009801369701A CN200980136970A CN102232073A CN 102232073 A CN102232073 A CN 102232073A CN 2009801369701 A CN2009801369701 A CN 2009801369701A CN 200980136970 A CN200980136970 A CN 200980136970A CN 102232073 A CN102232073 A CN 102232073A
- Authority
- CN
- China
- Prior art keywords
- alkyl
- pyridine
- imidazo
- propyl
- sec
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- URMVFILWXLQJIP-UHFFFAOYSA-N C(CNC1)c2c1[nH]cn2 Chemical compound C(CNC1)c2c1[nH]cn2 URMVFILWXLQJIP-UHFFFAOYSA-N 0.000 description 1
- 0 CC(C)C(C(NC)=C)NC(OC*=I)=O Chemical compound CC(C)C(C(NC)=C)NC(OC*=I)=O 0.000 description 1
- MIXNPMMZQNCPEG-UHFFFAOYSA-N CC(C)COC(N(CC1)C(C(C)C)c2c1nc[nH]2)=O Chemical compound CC(C)COC(N(CC1)C(C(C)C)c2c1nc[nH]2)=O MIXNPMMZQNCPEG-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Transplantation (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
化合物 | IC50(nM) |
实施例7 | 34 |
实施例14 | 48 |
实施例17 | 91 |
Claims (16)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0801979 | 2008-09-16 | ||
SE0801979-6 | 2008-09-16 | ||
US10673408P | 2008-10-20 | 2008-10-20 | |
US61/106,734 | 2008-10-20 | ||
PCT/EP2009/062011 WO2010031789A1 (en) | 2008-09-16 | 2009-09-16 | New compounds i |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102232073A true CN102232073A (zh) | 2011-11-02 |
CN102232073B CN102232073B (zh) | 2014-10-29 |
Family
ID=41226693
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200980136970.1A Expired - Fee Related CN102232073B (zh) | 2008-09-16 | 2009-09-16 | Ssao活性抑制剂 |
Country Status (16)
Country | Link |
---|---|
US (7) | US8263616B2 (zh) |
EP (1) | EP2334672B1 (zh) |
JP (1) | JP5539989B2 (zh) |
CN (1) | CN102232073B (zh) |
AU (1) | AU2009294660B2 (zh) |
BR (1) | BRPI0918602B8 (zh) |
CA (1) | CA2737527C (zh) |
DK (1) | DK2334672T3 (zh) |
EA (1) | EA019167B1 (zh) |
ES (1) | ES2440279T3 (zh) |
HK (1) | HK1159102A1 (zh) |
MX (1) | MX2011002581A (zh) |
NZ (1) | NZ592238A (zh) |
PL (1) | PL2334672T3 (zh) |
PT (1) | PT2334672E (zh) |
WO (1) | WO2010031789A1 (zh) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107074853A (zh) * | 2014-09-17 | 2017-08-18 | 普罗克斯马根有限公司 | 咪唑并[4,5‑c]吡啶衍生的SSAO抑制剂 |
CN107074854A (zh) * | 2014-09-17 | 2017-08-18 | 普罗克斯马根有限公司 | 咪唑并[4,5‑c]吡啶衍生的SSAO抑制剂 |
CN107531702A (zh) * | 2015-04-24 | 2018-01-02 | 普罗克斯马根有限公司 | 氨基脲敏感性胺氧化酶(ssao)抑制剂的药用盐形式 |
CN107530330A (zh) * | 2015-04-24 | 2018-01-02 | 普罗克斯马根有限公司 | 疼痛的治疗 |
CN107531701A (zh) * | 2015-04-24 | 2018-01-02 | 普罗克斯马根有限公司 | 作为氨基脲敏感性胺氧化酶(ssao)酶抑制剂的结晶化合物 |
CN113474346A (zh) * | 2018-12-28 | 2021-10-01 | 福马治疗有限公司 | 用于抑制泛素特异性蛋白酶1的组合物 |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT2334672E (pt) | 2008-09-16 | 2014-01-02 | Proximagen Ltd | Compostos novos i |
UA112154C2 (uk) | 2009-09-08 | 2016-08-10 | Біоті Терапіс Корп. | Застосування повністю людського анти-vap-1-антитіла для лікування фіброзних станів |
GB201004311D0 (en) | 2010-03-15 | 2010-04-28 | Proximagen Ltd | New enzyme inhibitor compounds |
CN102311396B (zh) * | 2010-07-05 | 2015-01-07 | 暨南大学 | 一种吡嗪类衍生物和其制备方法及在制药中的应用 |
FI20115234A0 (fi) | 2011-03-08 | 2011-03-08 | Biotie Therapies Corp | Uusia pyridatsinoni- ja pyridoniyhdisteitä |
EA201490451A1 (ru) | 2011-09-14 | 2014-12-30 | Проксимаген Лимитед | Новые соединения - ингибиторы ферментов |
GB201304526D0 (en) | 2013-03-13 | 2013-04-24 | Proximagen Ltd | New compounds |
GB201304527D0 (en) | 2013-03-13 | 2013-04-24 | Proximagen Ltd | New compounds |
US20160113893A1 (en) | 2013-06-12 | 2016-04-28 | Proximagen Limited | New therapeutic uses of enzyme inhibitors |
WO2015189534A1 (en) | 2014-06-12 | 2015-12-17 | Proximagen Limited | Vap-1 inhibitors for treating muscular dystrophy |
KR102041761B1 (ko) * | 2015-03-02 | 2019-11-06 | 닛본 덴끼 가부시끼가이샤 | 디코딩 장치, 수신기기, 송신기기, 송수신 시스템, 디코딩 방법, 및 디코딩 프로그램이 저장된 저장매체 |
GB201513115D0 (en) | 2015-07-24 | 2015-09-09 | Proximagen Ltd | New therapeutic compound and use in therapy |
EP3386494A1 (en) * | 2015-12-07 | 2018-10-17 | Benevolentai Cambridge Limited | Vap-1 inhibitors for treating pain |
GB201618029D0 (en) | 2016-10-25 | 2016-12-07 | Proximagen Ltd | New process |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002038163A1 (en) * | 2000-11-13 | 2002-05-16 | El Gendler | Bone putty and method |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5285191A (en) * | 1976-01-07 | 1977-07-15 | Farmaceutici Italia | Novel 4*5*6*77tetrahydroimidazoo *4*55c*pyridine derivative process for preparing same and medicine having antiiulcer antiisecretion and antiicolline activities containing same |
US4141899A (en) * | 1976-01-07 | 1979-02-27 | Societa' Farmaceutici Italia S.P.A. | 4,5,6,7-Tetrahydroimidazo-[4,5-c]-pyridine derivatives |
IT1098015B (it) * | 1978-08-07 | 1985-08-31 | Farmaceutici Italia | Nuovi 4,5,6,7,-tetraidroimidazo-aperta par.quadrata 4,5-c chiusa par.quadrata-piridin-derivati |
US6908926B1 (en) | 1999-04-16 | 2005-06-21 | Novo Nordisk A/S | Substituted imidazoles, their preparation and use |
SE0004101D0 (sv) * | 2000-11-09 | 2000-11-09 | Pharmacia Ab | New use |
AU2002214505A1 (en) * | 2000-11-09 | 2002-05-21 | Biovitrum Ab | New use of 4, 5, 6, 7-tetrahydroimidazo-(4,5-c)pyridine derivatives |
PT2334672E (pt) | 2008-09-16 | 2014-01-02 | Proximagen Ltd | Compostos novos i |
-
2009
- 2009-09-16 PT PT97830855T patent/PT2334672E/pt unknown
- 2009-09-16 ES ES09783085.5T patent/ES2440279T3/es active Active
- 2009-09-16 WO PCT/EP2009/062011 patent/WO2010031789A1/en active Application Filing
- 2009-09-16 EP EP09783085.5A patent/EP2334672B1/en active Active
- 2009-09-16 BR BRPI0918602A patent/BRPI0918602B8/pt not_active IP Right Cessation
- 2009-09-16 CA CA2737527A patent/CA2737527C/en not_active Expired - Fee Related
- 2009-09-16 JP JP2011526516A patent/JP5539989B2/ja active Active
- 2009-09-16 MX MX2011002581A patent/MX2011002581A/es active IP Right Grant
- 2009-09-16 DK DK09783085.5T patent/DK2334672T3/da active
- 2009-09-16 PL PL09783085T patent/PL2334672T3/pl unknown
- 2009-09-16 EA EA201100391A patent/EA019167B1/ru not_active IP Right Cessation
- 2009-09-16 AU AU2009294660A patent/AU2009294660B2/en not_active Ceased
- 2009-09-16 US US13/062,318 patent/US8263616B2/en active Active
- 2009-09-16 NZ NZ592238A patent/NZ592238A/xx not_active IP Right Cessation
- 2009-09-16 CN CN200980136970.1A patent/CN102232073B/zh not_active Expired - Fee Related
-
2011
- 2011-12-16 HK HK11113628.0A patent/HK1159102A1/zh not_active IP Right Cessation
-
2012
- 2012-08-06 US US13/567,146 patent/US8569338B2/en active Active
-
2013
- 2013-10-25 US US14/062,969 patent/US9035066B2/en active Active
-
2015
- 2015-04-13 US US14/684,813 patent/US9493457B2/en active Active
-
2016
- 2016-10-27 US US15/335,751 patent/US9890160B2/en active Active
-
2017
- 2017-12-29 US US15/858,407 patent/US10399973B2/en active Active
-
2019
- 2019-07-17 US US16/514,413 patent/US11040969B2/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002038163A1 (en) * | 2000-11-13 | 2002-05-16 | El Gendler | Bone putty and method |
Non-Patent Citations (1)
Title |
---|
G.ARCARI,ET AL.: "Anti-ulcer and Antisecretory Activity of Selected Imidazopiperidines", 《ARZNEIMITTEL-FORSCHUNG》 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107074853A (zh) * | 2014-09-17 | 2017-08-18 | 普罗克斯马根有限公司 | 咪唑并[4,5‑c]吡啶衍生的SSAO抑制剂 |
CN107074854A (zh) * | 2014-09-17 | 2017-08-18 | 普罗克斯马根有限公司 | 咪唑并[4,5‑c]吡啶衍生的SSAO抑制剂 |
CN107074854B (zh) * | 2014-09-17 | 2019-07-19 | 普罗克斯马根有限责任公司 | 咪唑并[4,5-c]吡啶衍生的SSAO抑制剂 |
CN107074853B (zh) * | 2014-09-17 | 2019-07-23 | 普罗克斯马根有限责任公司 | 咪唑并[4,5-c]吡啶衍生的SSAO抑制剂 |
CN107531702A (zh) * | 2015-04-24 | 2018-01-02 | 普罗克斯马根有限公司 | 氨基脲敏感性胺氧化酶(ssao)抑制剂的药用盐形式 |
CN107530330A (zh) * | 2015-04-24 | 2018-01-02 | 普罗克斯马根有限公司 | 疼痛的治疗 |
CN107531701A (zh) * | 2015-04-24 | 2018-01-02 | 普罗克斯马根有限公司 | 作为氨基脲敏感性胺氧化酶(ssao)酶抑制剂的结晶化合物 |
CN112851669A (zh) * | 2015-04-24 | 2021-05-28 | 博善人工智能剑桥有限公司 | 氨基脲敏感性胺氧化酶(ssao)抑制剂的药用盐形式 |
CN113474346A (zh) * | 2018-12-28 | 2021-10-01 | 福马治疗有限公司 | 用于抑制泛素特异性蛋白酶1的组合物 |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102232073B (zh) | Ssao活性抑制剂 | |
CN102695708B (zh) | N1-吡唑并螺酮乙酰辅酶a羧化酶抑制剂 | |
KR101991327B1 (ko) | 오피오이드 수용체 리간드와 그 용도 및 제조방법 | |
CN103889983B (zh) | 酶抑制剂化合物 | |
JP5479488B2 (ja) | フェニルピリミドン骨格を有する化合物、その薬剤組成物、その製造方法及び用途 | |
JP2019503389A (ja) | Pde1阻害剤 | |
WO2020035020A1 (zh) | 咪唑并吡啶类衍生物及其制备方法和其在医药上的用途 | |
JP2023544431A (ja) | Jakキナーゼ阻害剤としての小分子化合物及びその用途 | |
KR20230153387A (ko) | Gpr84 길항제 및 이의 용도 | |
JP2024506858A (ja) | Gpr84アンタゴニストおよびその使用 | |
EP3186257B1 (en) | Novel chromone oxime derivative and its use as allosteric modulator of metabotropic glutamate receptors | |
CN103459380A (zh) | 新型的苯基吡啶衍生物及含有该衍生物的医药 | |
JP5569816B2 (ja) | イミダゾール誘導体 | |
JP2017095411A (ja) | ピラゾール誘導体の塩の結晶 | |
EP4032891A1 (en) | Pyridine derivatives as modulators of sortilin activity | |
WO2024028364A1 (en) | Aryl-triazolyl and related gpr84 antagonists and uses thereof | |
Sharma et al. | Design, synthesis, characterization and biological evaluation of some novel 5, 6-substitute-1-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-2-trifluoromethyl-1H-benzoimidazol for their potential antihypertensive agents | |
CN103936737A (zh) | 黄嘌呤衍生物 | |
KR20190121766A (ko) | 아미드 유도체 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1159102 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1159102 Country of ref document: HK |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: London, England Patentee after: Boshan Artificial Intelligence Cambridge Co.,Ltd. Address before: London, England Patentee before: PROXIMAGEN LTD. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20141029 Termination date: 20210916 |